id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-4282-0001,FDA,FDA-2018-N-4282,"Endocrinologic and Metabolic Drugs Advisory Committee; Notice of
Meeting; Establishment of a Public Docket; Request for Comments",Notice,Request for Comments,2018-11-30T05:00:00Z,2018,11,2018-11-30T05:00:00Z,2019-01-17T04:59:59Z,2019-01-18T02:00:40Z,2018-25990,0,0,090000648391601c